Shenzhen's foremost destination for dermatology and skin cancer — and a growing precision oncology hub with direct access to Peking University's CAR-T clinical trial network. The International Medical Centre provides private-level intake within a public hospital, making world-class expertise accessible to international patients without private hospital pricing.
Peking University Shenzhen Hospital (北京大学深圳医院) was established in 1999 as a direct branch of China's most prestigious university hospital system. Situated in Futian District — Shenzhen's administrative and financial centre — it holds Grade 3A status and functions as one of the city's primary referral hospitals for both dermatology and cancer care.
The hospital's dermatology department has been designated a national clinical centre of excellence and sees case volumes that few other hospitals in China match. For oncology patients, the connection to Peking University's broader academic network means access to clinical trial pipelines and NGS genomic profiling protocols that feed directly from PKU research programmes in Beijing. The IMC provides a dedicated intake path for international patients, operated separately from the main outpatient flow.
The dermatology department holds national clinical centre designation and manages the full spectrum of skin conditions — from autoimmune skin disease to melanoma and cutaneous lymphoma. For patients with complex skin presentations or skin cancer requiring specialist second opinion, this is one of the strongest departments in southern China. International patients can access the department through the IMC with a proxy consultation arranged by China Care in advance of travel.
As a PKU-affiliated hospital, this Shenzhen campus has access to the Peking University clinical trial pipeline — including CAR-T cell therapy protocols and haematology trials that originate from the Peking University People's Hospital network. For patients who need CAR-T but prefer Shenzhen's proximity to Hong Kong, this hospital provides a viable entry point to PKU-network oncology expertise without travelling to Beijing.
The International Medical Centre operates with dedicated staff, a separate patient flow, and a service standard closer to a private hospital. International patients receive bilingual case coordination, dedicated consultation scheduling, and a designated liaison throughout their stay — at public hospital treatment pricing. China Care coordinates directly with the IMC, pre-clearing your case before you travel.
The departments most commonly accessed by international patients coordinated through China Care.
China Care coordinates the full intake process for international patients — from initial record review through to on-the-ground support during your stay in Shenzhen.
Send your medical records, pathology reports, and imaging to China Care. For dermatology or skin oncology cases, include photos and any prior biopsy results. For oncology cases, include complete treatment history and current blood panel. We review your records and prepare a bilingual case summary within 1–2 working days.
records review · 1–2 daysChina Care attends PKU Shenzhen Hospital in person and consults directly with the relevant specialist — on your behalf, before you travel. The doctor reviews your case summary, indicates whether treatment is suitable, and gives an initial direction. China Care reports the outcome back to you with voice call interpretation in real time during the consultation.
This service is charged at a fixed fee, which covers hospital registration, the in-person proxy consultation, and real-time voice interpretation. Already in China? Skip this step — China Care can arrange direct escort and interpretation for your own visit instead.
proxy consultation · fixed fee · results same dayArmed with the specialist's initial direction, you travel to Shenzhen for your own in-person consultation at the IMC. The specialist reviews your case in full, confirms the treatment plan, and provides a formal cost estimate — this cannot be completed remotely at a public hospital. For oncology cases, NGS genomic profiling is typically initiated at this appointment. China Care's bilingual coordinator accompanies you throughout.
in-person consultation · treatment plan & cost estimate issuedOnce you agree to proceed, admission is arranged through the IMC. China Care's coordinator remains on hand during your stay — accompanying you to ward rounds, follow-up appointments, and administrative processes. Ward nursing staff and hospital administration operate primarily in Mandarin, so on-site escort is strongly recommended for non-Chinese speakers.
All treatment fees are paid directly to the hospital in Chinese yuan (RMB). PKU Shenzhen Hospital does not accept international credit cards for inpatient treatment. A deposit is required at admission; the balance is settled before discharge. China Care does not collect or handle medical payments.
IMC admission · RMB payment direct to hospitalComplete bilingual discharge documentation is issued on the day of discharge. For oncology patients requiring follow-up genomic testing or treatment monitoring, China Care can coordinate remote check-ins with the specialist team depending on the individual physician's availability. Post-discharge coordination with your home physician is also available on request.
bilingual documentation · post-discharge supportSubmit your records to China Care. We conduct a proxy consultation on your behalf and report back before you commit to travelling.
China Care coordinates your case with PKU Shenzhen Hospital's International Medical Centre. Treatment costs are quoted directly by the hospital. We never add to or mark up the hospital's quoted treatment cost.